IQAI Iq-ai Limited

TIDMIQAI

RNS Number : 9734S

IQ-AI Limited

09 November 2023

IQ-AI Ltd

("IQ-AI" or the "Company")

Director Dealing and Conversion of Convertible Loan Notes

IQ-AI Ltd has received a conversion notice from Trevor Brown, the CEO of IQ-AI, converting GBP100,000 convertible loan notes and associated interest, issued on 29 May 2019, at a price of 1.5 pence, into 8,446,393 Ordinary Shares ("CLN Shares").

Following the above transactions, Trevor Brown will hold 40,649,850 Ordinary Shares, representing approximately 21.32 per cent. of the Company's enlarged issued ordinary share capital.

An application will be made for 8,446,393 CLN Shares to be admitted to the Official List of the UK Listing Authority by way of a Standard Listing ("Admission") and it is expected that Admission will become effective and that dealing in the CLN Shares will commence on or around 8am on 15 November 2023. The CLN Shares will rank pari passu with the existing ordinary shares of the Company.

Following Admission, the Company will have 190,671,542 ordinary shares of 0.01p each in issue, none of which are held in treasury. Therefore, the total number of voting rights in the Company will be 190,671,542.

The above figure of 190,671,542 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

--ENDS -

The Directors of the Company accept responsibility for the contents of this announcement.

For further information, please contact:

 
 IQ-AI Ltd 
  Trevor Brown/Vinod Kaushal/Brett Skelly/Michael Schmainda 
  Tel: 020 7469 0930 
 Peterhouse Capital Limited (Financial Adviser and Broker) 
  Lucy Williams/Heena Karani 
  Tel: 020 7220 9797 
 

About Imaging Biometrics(R) LLC : IB is a wholly owned subsidiary of IQ-AI Limited, (LON: IQAI), and focuses on delivering quantitative imaging platforms and therapeutics that transform how clinicians diagnose and treat patients more efficiently and effectively. For more information about Imaging Biometrics, visit the company's

website at www.imagingbiometrics.com .   Follow IB on Twitter, @IQAI_IB. 

PDMR DEALINGS

 
     Notification and public disclosure of transactions by persons 
      discharging managerial responsibilities and persons closely 
                         associated with them. 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
     ----------------------------------------------------------------- 
 a)   Name                     Trevor Brown 
     -----------------------  ---------------------------------------- 
 2    Reason for the notification 
     ----------------------------------------------------------------- 
 a)   Position/status          CEO 
     -----------------------  ---------------------------------------- 
 b)   Initial notification 
       /Amendment                Initial 
     -----------------------  ---------------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ----------------------------------------------------------------- 
 a)   Name                     IQ-AI Ltd 
     -----------------------  ---------------------------------------- 
 b)   LEI                      213800SPW48XRJS2QH57 
     -----------------------  ---------------------------------------- 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
     ----------------------------------------------------------------- 
 a)   Description              Ordinary Shares of GBP0.01 each 
       of the financial 
       instrument, 
       type of instrument 
       Identification           ISIN: JE00BD4H0R42 
       code 
     -----------------------  ---------------------------------------- 
 b)   Nature of the            Conversion of convertible loan notes 
       transaction 
     -----------------------  ---------------------------------------- 
 c)   Price(s) and             Exercise price of each convertible loan 
       volume(s)                note :1.5p 
                                Volume: 8,446,393 
     -----------------------  ---------------------------------------- 
 d)   Aggregated information 
       - Aggregated 
       volume 
       - Price 
     -----------------------  ---------------------------------------- 
 e)   Date of the              9 November 2023 
       transaction 
     -----------------------  ---------------------------------------- 
 f)   Place of the             Main Market 
       transaction 
     -----------------------  ---------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFSWFFUEDSEDF

(END) Dow Jones Newswires

November 09, 2023 06:38 ET (11:38 GMT)

Iq-ai (LSE:IQAI)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024

Iq-ai (LSE:IQAI)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024